Peptide receptor radionuclide therapy in a case of multiple spinal canal and cranial paragangliomas

Journal of Clinical Oncology

Volumn 29, Issue 7, 2011, Pages

  Cecchin, Diego ^a   Schiavi, Francesca ^b   Fanti, Stefano ^c   Favero, Marta ^a   Manara, Renzo ^a   Fassina, Ambrogio ^a   Briani, Chiara ^a   Allegri, Vincenzo ^c   Sansovini, Maddalena ^d   Bui, Franco ^a   Paganelli, Giovanni ^e   Opocher, Giuseppe ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d DEPARTMENT OF MEDICAL ONCOLOGY   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; CHROMOGRANIN A1; DOTANOC GA 68; PENTETREOTIDE; PENTETREOTIDE IN 111; PROTEIN S 100; RADIOISOTOPE; SOMATOSTATIN RECEPTOR; SUCCINATE DEHYDROGENASE; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN TUMOR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; EPENDYMOMA; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PRIORITY JOURNAL; RADIOISOTOPE THERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPINE SURGERY; SPINE TUMOR; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; BIOPSY, NEEDLE; BRAIN NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; LOW BACK PAIN; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PARAGANGLIOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RECEPTORS, PEPTIDE; RISK ASSESSMENT; SPINAL CORD NEOPLASMS; TREATMENT OUTCOME;

EID: 79952332269     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.7131     Document Type: Article

References (23)

1. Thines L, Lejeune JP, Ruchoux MM, et al: Management of delayed intracranial and intraspinal metastases of intradural spinal paragangliomas. Acta Neurochir (Wien) 148:63-66, 2006 (Pubitemid 41821458)
2. Blades DA, Hardy RW, Cohen M: Cervical paraganglioma with subsequent intracranial and intraspinal metastases: Case report. J Neurosurg 75:320-323, 1991
3. Strommer KN, Brandner S, Sarioglu AC, et al: Symptomatic cerebellar metastases and late local recurrence of a cauda equina paraganglioma: Case report. J Neurosurg 83(1):166-169, 1995
4. Roche PH, Figarella-Branger D, Regis J, et al: Cauda equina paraganglioma with subsequent intracranial and intraspinal metastases. Acta Neurochir (Wien) 138:475-479, 1996 (Pubitemid 26125024)
5. Kimura N, Watanabe T, Noshiro T, et al: Histological grading of adrenal and extra-adrenal pheochromocytomas and relationship to prognosis: A clinicopathological analysis of 116 adrenal pheochromocytomas and 30 extra-adrenal sympathetic paragangliomas including 38 malignant tumors. Endocr Pathol 16:23-32, 2005 (Pubitemid 41278311)
6. Thompson LD: Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from malignant neoplasms: A clinicopathologic and immunophenotypic study of 100 cases. Am J Surg Pathol 26:551-566, 2002
7. Yang SY, Jin YJ, Park SH, et al: Paragangliomas in the cauda equina region: Clinicopathoradiologic findings in four cases. J Neurooncol 72:49-55, 2005 (Pubitemid 41149177)
8. Zileli M, Kalayci M, and Baçsdemir G: Paraganglioma of the thoracic spine. J Clin Neurosci 15:823-827, 2008
9. Aggarwal S, Deck JH, Kucharczyk W: Neuroendocrine tumor (paraganglioma) of the cauda equina: MR and pathologic findings. AJNR Am J Neuroradiol 14:1003-1007, 1993 (Pubitemid 23213395)
10. Hayes E, Lippa C, Davidson R: Paragangliomas of the cauda equina. AJNR Am J Neuroradiol 10(5 Suppl):S45-S47, 1989 (Pubitemid 19219685)
11. Constantini S, Soffer D, Siegel T, et al: Paraganglioma of the thoracic spinal cord with cerebrospinal fluid metastases. Spine 14:643-645, 1989 (Pubitemid 19157192)
12. Neumann HP, Pawlu C, Peczkowska M, et al: Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA 292:943-951, 2004 (Pubitemid 39097204)
13. Schiavi F, Boedeker CC, Bausch B, et al: Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. JAMA 294:2057-2063, 2005 (Pubitemid 41539939)
14. Hao HX, Khalimonchuk O, Schraders M, et al: SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma. Science 325:1139-1142, 2009
15. Eisenhofer G, Bornstein SR, Brouwers FM, et al: Malignant pheochromocytoma: Current status and initiatives for future progress. Endocr Relat Cancer 11:423-436, 2004 (Pubitemid 39331275)
16. Boedeker CC, Neumann HP, Maier W, et al: Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg 137: 126-129, 2007 (Pubitemid 46962136)
17. Mössner R, Keidel M: Malignant pheochromocytoma with progressive paraparesis in von Hippel-Lindau disease. Eur J Neurol 7:439-442, 2000 (Pubitemid 32280907)
18. Walther MM, Herring J, Enquist E, et al: von Recklinghausen's disease and pheochromocytomas. J Urol 162:1582-1586, 1999 (Pubitemid 29474665)
19. van Nederveen FH, Gaal J, Favier J, et al: An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: A retrospective and prospective analysis. Lancet Oncol 10:764-771, 2009
20. Forrer F, Riedweg I, Maecke HR, et al: Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma. Q J Nucl Med Mol Imaging 52:334-340, 2008
21. 68Ga-labelled DOTA-derivatised peptide ligands. Eur J Nucl Med Mol Imaging 31:1097-1104, 2004
22. Grozinsky-Glasberg S, Grossman AB, Korbonits M: The role of somatostatin analogues in the treatment of neuroendocrine tumours. Mol Cell Endocrinol 286:238-250, 2008 (Pubitemid 351689003)
23. Kwekkeboom DJ, de Herder WW, Kam BL, et al: Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: Toxicity, efficacy, and survival. J Clin Oncol 26:2124-2130, 2008